In IDH‐mutant gliomas, relative cerebral blood volume (rCBV) values are typically lower and more uniformly distributed, likely due to the inhibitory effects of 2‐hydroxyglutarate on hypoxia and angiogenesis as well as the ubiquitous expression of IDH mutations across tumor cells [5, 12]. Here, IDH2 is linked to central nervous system cancer.